Unlocking the Potential of Rucaparib: A Case Series on Its Impact in Metastatic Breast Cancer With Mutations

Triple-negative breast cancer poses distinct challenges because it lacks hormone receptors and does not have human epidermal growth factor receptor 2 (HER2) amplification. Mutations in BRCA1/2 genes are associated with homologous recombination deficiency tumors, rendering them susceptible to poly (A...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Curēus (Palo Alto, CA) CA), 2024-05, Vol.16 (5), p.e60963
Hauptverfasser:	Mv, Chandrakanth, Agarwala, Vivek, Choudhary, Neha, Sharma, Amit, Roy, Minakshi, Mandal, Kaustav, Basu, Moinak, Sen, Nibedita, Sarkar, Pritam K, Kumar, Subhabrata
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer FDA approval Mutation Oncology Ovarian cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!